CORONAVIRUS UPDATES: Select the "more info" link for coronavirus-related resources and updates for Liberal Arts students, faculty, and staff. More info >

Current Funding Opportunities

You are here: Home / Research / Grants & Contracts Office / Current Funding Opportunities

Title: Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection

Sponsor: National Institutes of Health, National Institute on Drug Abuse (NIDA)

Deadline: Applications accepted January 4, 2021 to September 8, 2024

Amount: Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice:

PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)

PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)

PA-20-195 - NIH Exploratory/Developmental Research Grant (Parent R21Clinical Trial Not Allowed)

Description: COVID-19 virus attaches to the angiotensin-converting enzyme 2 (ACE 2) receptor, abundant in cardiac, lung, renal, liver and vascular organs, triggering massive cytokine responses. Recent studies suggest possible pathogenic roles between nicotine and angiotensin-2 receptors, investigations which are critical for understanding the multisystem pathogenesis of COVID-19, in which bradykinins and pro-inflammatory cytokines and chemokines play significant roles. Thus, studying the medical consequences of smoking and vaping in most vulnerable populations is of scientific relevance, especially in the elderly; in individuals with diabetes mellitus, hypertension or obesity; in individuals with chronic diseases of organs and systems rich in ACE-2 receptors; and in SUD and HIV populations. NIDA is interested in receiving research applications focusing on individuals who smoke or vape either marijuana and/or tobacco to determine: 1) the risk of contracting a COVID-19 infection, 2) the effects on asymptomatic COVID-19 infected persons, and 3) the course of the COVID-19 infection.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: Law & Science (LS)

Sponsor: National Science Foundation (NSF)

Deadline: January 15, 2021

Amount: Funding limits are not described, but click here to see the amounts for other grants funded by LS.

Description: LS considers proposals that address social scientific studies of law and law-like systems of rules, as well as studies of how science and technology are applied in legal contexts. The Program is inherently interdisciplinary and multi-methodological. Successful proposals describe research that advances scientific theory and understanding of the connections between human behavior and law, legal institutions, or legal processes; or the interactions of law and basic sciences, including biology, computer and information sciences, STEM education, engineering, geosciences, and math and physical sciences. Scientific studies of law often approach law as dynamic, interacting with multiple arenas, and with the participation of multiple actors.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: More Info: See Proposal Solicitation.


Title: Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Deadline: January 26, 2021

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.

Description: /PIs must be designated Early Stage Investigators (ESI) by NIH as defined in NOT-OD-17-101. The purpose of this FOA is to provide a new pathway for Early Stage Investigators (ESIs) who wish to propose research projects in a new direction for which preliminary data do not exist. The Stephen I. Katz Early Stage Investigator Research Project Grant, named in honor of the late National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Director, Stephen I. Katz, M.D., Ph.D., is open to a broad range of scientific research relevant to the mission of the participating NIH Institutes and Centers (ICs). Proposed projects must represent a change in research direction for the ESI and should be innovative and unique. A distinct feature for this FOA is that applications must not include preliminary data. This FOA is appropriate for ESIs who wish to initiate a research project in an area different from their previous research focus and/or training experience, and therefore have not produced preliminary data. PD/PI's who wish to proposed research projects consistent with their past work or training and/or supported by preliminary data, should apply to the Parent R01 or other FOAs allowing for preliminary data. Proposed research projects can rely on the PD/PI’s prior work and expertise as its foundation, but must not be an incremental advancement, expansion, or extension of a previous research effort. The change in research direction could involve, for example, a new approach, methodology, technique, discipline, therapeutic target, and/or new paradigm, different from the ESI’s previous research efforts. Importantly, the proposed direction must represent a change in research direction for the PD/PI. Because a change in research direction is heavily dependent upon the area of investigation, potential applicants are strongly encouraged to contact a program director to discuss their proposed project. If the application proposes multiple Principal Investigators (MPIs), all PD/PIs must be ESIs and the research direction must be a change in research direction for all MPIs. Please note that the application must describe how the proposed new research direction is different from the ESI’s past work in a separate attachment entitled “New Research Directions” (see Section IV, SF424(R&R) Other Project Information).

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required)

Sponsor: National Institutes of Health

Deadline: January 26, 2021

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.

Description: /PIs must be designated Early Stage Investigators (ESI) by NIH as defined in NOT-OD-17-101. The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Funding Opportunity Announcement (FOA) must not include preliminary data. Applications must include a separate attachment describing the change in research direction.The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. This FOA is for basic science experimental studies involving humans, referred to in NOT-OD-18-212 as “prospective basic science studies involving human participants.” These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Studies that are NOT conducted with specific applications toward processes or products in mind and which also do not meet the clinical trial definition should submit under the appropriate ‘Clinical Trial Not Allowed’ FOA.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Deadline: February 5, 2021

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.

Description: This R01 supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. This Funding Opportunity Announcement does not accept applications proposing clinical trial(s).

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: Research Project Grant (Parent R01 Clinical Trial Required)

Sponsor: National Institutes of Health

Deadline: February 5, 2021

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.

Description: This R01 supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Applicants should note that some ICs Related Notices) only accept applications proposing mechanistic studies that meet NIH's definition of a clinical trial through this funding opportunity announcement.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)

Sponsor: National Institutes of Health

Deadline: February 5, 2021

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.

Description: This R01 supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Funding Opportunity Announcement is for basic science experimental studies involving humans, referred to in NOT-OD-18-212 as “prospective basic science studies involving human participants.” These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Studies conducted with specific applications toward processes or products in mind should submit under the appropriate ‘Clinical Trials Required’ or ‘Clinical Trial Optional’ FOA. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Deadline: February 16, 2021

Amount: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Description: The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. This Funding Opportunity Announcement does not accept applications proposing clinical trial(s). Applicants are encouraged to identify a participating IC that supports their area of research via the R21 IC-Specific Scientific Interests and Contact website and contact Scientific/Research staff from relevant ICs to inquire about their interest in supporting the proposed research project.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)

Sponsor: National Institutes of Health

Deadline: February 16, 2021

Amount: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Description: The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. Not all NIH Institutes and Centers (ICs) participate in Parent Announcements. Applicants should carefully note which ICs participate in this announcement and view their respective areas of research interest at the R21 Clinical Trial Required IC-Specific Scientific Interests and Contact website. ICs that do not participate in this announcement will not consider applications for funding.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)

Sponsor: National Institutes of Health

Deadline: February 16, 2021

Amount: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Description: The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. This Parent Funding Opportunity Announcement is for basic science experimental studies involving humans, referred to in NOT-OD-18-212 as “prospective basic science studies involving human participants.” These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Studies conducted with specific applications toward processes or products in mind should submit under the appropriate ‘Clinical Trials Required’ or ‘Clinical Trial Optional’ FOA. Note: Not all NIH Institutes and Centers (ICs) participate in Parent Announcements. Applicants should carefully note which ICs participate in this announcement and view their respective areas of research interest at the R21 Basic Experimental Studies with Humans Required IC-Specific Scientific Interests and Contact website. ICs that do not participate in this announcement will not consider applications for funding.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)

Sponsor: National Institutes of Health

Deadline: April 8, 2021

Amount: Award budgets are composed of stipends, tuition and fees, and institutional allowance, as described at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-070.html

Description: The purpose of this F31 is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from diverse backgrounds including those from groups that are underrepresented in the biomedical, behavioral, or clinical research workforce. Through this award program, promising predoctoral students will obtain individualized, mentored research training from outstanding faculty sponsors while conducting well-defined research projects in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training is expected to clearly enhance the individual's potential to develop into a productive, independent research scientist. This Funding Opportunity Announcement (FOA) does not allow candidates to propose to lead an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

Sponsor: National Institutes of Health

Deadline: April 8, 2021

Amount: Award budgets are composed of stipends, tuition and fees, and institutional allowance, as described at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-070.html

Description: The F31 enables promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the candidate’s dissertation research project and is expected to clearly enhance the individual’s potential to develop into a productive, independent research scientist. This FOA is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)

Sponsor: National Institutes of Health

Deadline: April 8, 2021

Amount: Award budgets are composed of stipends, tuition and fees, and institutional allowance, as described at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-070.html

Description: The F32 supports research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers. Applications are expected to incorporate exceptional mentorship. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: Non-Academic Research Internships for Graduate Students (INTERN) Supplemental Funding Opportunity

Sponsor: National Science Foundation

Deadline: Applications accepted until April 15, 2021

Amount: The total amount of funding requested must not exceed $55,000 per student per six-month period.

Description: The PI/co-PI of an active NSF award may request supplemental funding for one or more graduate students to gain knowledge, skills and experiences that will augment their preparation for a successful long-term career through an internship in a non-academic setting, including the following:

  • For-profit industry laboratories or industry research and development groups
  • Start-up businesses, such as (but not limited to) those funded through the NSF's Small Business Innovation Research (SBIR) program and Small Business Technology Transfer (STTR) program
  • Government agencies (all levels) and National Laboratories
  • Museums, science centers, and other informal learning settings
  • Policy think-tanks Non-profit organizations.

PIs are encouraged to discuss with the cognizant NSF program director activities that are synergistic with the NSF project scope. It is expected that the graduate student and the PI on the NSF grant will work together to identify innovative experiences that add the most educational value for the graduate student through activities that are not already available at the student's academic institution. Further, it is expected that the internship will be research-focused in a STEM field or in STEM education research and will be on-site at the host organization unless a specific exception to this is granted due to extenuating circumstances by the cognizant program officer.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Title: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

Sponsor: National Institutes of Health (NIH)

Deadline: Applications accepted until May 8, 2023

Amount: Application budgets are limited to no more than the amount of the current parent award and must reflect the actual needs of the proposed project. Direct costs for individual administrative supplements vary from less than $5,000 to more than $100,000 depending on the career level of the candidate. Administrative supplements end with the currently funded competitive cycle of the parent grant. Budget requests may also be limited by the awarding IC. See Table of IC-Specific Information, Requirements and Staff Contacts for more details.

Description: For PIs holding specific types of research grants funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PIs of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: Funding Opportunity Announcement


Title: Archaeology and Archaeometry Doctoral Dissertation Research (DDRI)

Sponsor: National Science Foundation

Deadline: Applications Accepted Anytime

Amount: The DDRI competition provides up to $20,000 (+ university indirect/overhead costs).

Description: The goal of the Archaeology Program is to fund research which furthers anthropologically relevant archaeological knowledge. In accordance with the National Science Foundation’s mission such research has the potential to provide fundamental scientific insight. While within the broad range of “archaeology” the focus is on projects judged to be significant from an anthropological perspective, the Program sets no priorities based on time period, geographic region or specific research topic. For a detailed description of the Archaeology Program DDRI competition, see Solicitation NSF 15-554 which can be accessed via the Archaeology DDRI web site. It contains additional rules not presented in this synopsis. The DDRI competition provides up to $20,000 (+ university indirect/overhead costs) to permit graduate students enrolled in US universities to conduct dissertation research. The student need not be a US citizen or national. While the student writes the proposal and conducts/supervises the research, the dissertation advisor serves as the Principal Investigator and the student is listed as the Co-PI. Salary and normal living expenses are not eligible costs but per diem and most other research expenses are allowable. Both field and non-field projects are funded. Proposals may be submitted at any time and applicants are normally informally notified of the likely outcome within three months. Applications are sent for evaluation to six individuals (“ad hoc reviewers”) specifically selected for subject matter expertise. Students are allowed to resubmit one time if their original proposal is declined. Unless Program Officer dispensation is obtained, a student, through their advisor, may submit only two proposals (an original submission and a resubmission if necessary).

How to Apply: Notify RGSO of your plan to submit a proposal. The preaward team will work with you to help you complete your proposal, and RGSO will submit your proposal.

More Info: See Proposal Solicitation.


Return to Top